Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Grandy House, Oct-Dec (3Q) Ordinary Profit Increases by 2.1 times
8999 Grandy House Corporation 【J-GAAP】
Earnings ReportGrandy House Corporation <8999> [TSE Prime] announced its financial results after the market closed on February 13th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2025 (April to December) decreased 15.5% from the same period last year to 0.49 billion yen. The progress rate toward the full-year plan of 1 billion yen was 49.5%, also falling below the five-year average of 70.3%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to expand 73.5% from the same period last year, reaching 0.5 billion yen.
In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit surged 2.1 times that of the same period last year, reaching 0.24 billion yen. The operating profit margin improved from 1.5% in the same period last year to 2.1%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Dec, 2022 | 40,689 | 2,586 | 2,433 | 1,677 | 57.7 | 78.4 | Feb 13, 2023 | J-GAAP |
Apr - Dec, 2023 | 37,502 | 781 | 586 | 314 | 10.9 | 66.8 | Feb 13, 2024 | J-GAAP |
Apr - Dec, 2024 | 39,996 | 712 | 495 | 218 | 7.7 | 49.5 | Feb 13, 2025 | J-GAAP |
YoY | +6.7% | -8.8% | -15.5% | -30.6% | -30.0% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 26,795 | 592 | 407 | 165 | 5.8 | 32 | May 13, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | 27,017 | 866 | 745 | 523 | 18.2 | 32 | Nov 13, 2024 | J-GAAP |
YoY | +0.8% | +46.3% | +83.0% | +217.0% | +216.1% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 55,205 | 3,329 | 3,103 | 2,168 | 74.5 | 32 | May 12, 2023 | J-GAAP |
Mar, 2024 | 51,521 | 1,175 | 877 | 416 | 14.5 | 32 | May 13, 2024 | J-GAAP |
Mar, 2025 Guidance | 54,000 | 1,300 | 1,000 | 600 | 20.9 | 32 | May 13, 2024 | J-GAAP |
YoY | +4.8% | +10.6% | +14.0% | +44.2% | +43.9% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 12,776 | 198 | 116 | 63 | 2.2 | 1.5 | Feb 13, 2024 | J-GAAP |
Jan - Mar, 2024 | 14,019 | 394 | 291 | 102 | 3.6 | 2.8 | May 13, 2024 | J-GAAP |
Apr - Jun, 2024 | 12,832 | 116 | 25 | -59 | -2.1 | 0.9 | Aug 9, 2024 | J-GAAP |
Jul - Sep, 2024 | 14,151 | 318 | 230 | 136 | 4.8 | 2.2 | Nov 13, 2024 | J-GAAP |
Oct - Dec, 2024 | 13,013 | 278 | 240 | 141 | 5.0 | 2.1 | Feb 13, 2025 | J-GAAP |
YoY | +1.9% | +40.4% | +106.9% | +123.8% | +126.0% |
Related Articles
DAIKOKU DENKI, Oct-Dec (3Q) Ordinary Profit Decreases by 28%
Kakuyasu Group, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 30%, Oct-Dec Ordinary Profit Decreases by 23%
SENKO, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 11%, Oct-Dec Ordinary Profit Increases by 13%
StemCell Institute, Oct-Dec (3Q) Ordinary Profit Decreases by 27%
PORT, Apr-Dec (Cumulative 3Q) Net Income Increases by 35%, Oct-Dec Net Income Increases by 98%
GINZA YAMAGATAYA, Apr-Dec (Cumulative 3Q) Net Income Turns to Loss, Oct-Dec Net Income Decreases by 36%
Raysum, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 59%, Oct-Dec Ordinary Profit Turns to Loss
CHANGE Holdings, Oct-Dec (3Q) Net Income Increases by 61%
Innovation Holdings, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 42%, Oct-Dec Ordinary Profit Increases by 90%
KLab, Last Fiscal Year's Ordinary Profit Loss Widens, Current period performance is undisclosed.